Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Q07343 (PDE4B_HUMAN) Homo sapiens (Human)

3',5'-cyclic-AMP phosphodiesterase 4B UniProtKBInterProSTRINGInteractive Modelling

736 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4); 1 identical sequence: Homo sapiens: X5DNX5

Available Structures

40 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of crosslink stabilized long-form PDE4Bhomo-2-mer166-657
ZN;NA;MG;IOD;
Assess
Crystal structure of crosslink stabilized long-form PDE4B in complex with (R)-(-)-rolipramhomo-2-mer166-657
ZN;IOD;ROL;MG;
Assess
Crystal structure of human phosphodiesterase 4b with regulatory domain and d155988homo-2-mer247-658
ZN;MG;988;
Assess
Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with a Quinoline Inhibitorhomo-2-mer325-659
SK4;ZN;MG;ARS;GOL;
Assess
Catalytic domain of human phosphodiesterase 4B2B in complex with a tetrahydrobenzothiophene inhibit…monomer324-683
ZN;MG;HBT;GOL;
Assess
Crystal structure of phosphodiesterase 4B in complex with compound 31emonomer326-683
NVW;ZN;CA;
Assess
Crystal structure of phosphodiesterase 4B in complex with compound 10fmonomer326-683
QPC;ZN;CA;
Assess
CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2Bmonomer324-680
ZN;MG;ARS;
Assess
Selective Inhibition of the Catalytic Domain Of Human Phosphodiesterase 4B With A-33monomer324-680
19T;MG;ZN;NA;EDO;
Assess
PDE4 catalytic domainmonomer324-680
ZN;MG;NA;2O5;EDO;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Mesoprammonomer335-685
ZN;MG;5RM;
Assess
Crystal structure of human PDE4b with 5-[3-[(1S,2S,4R)-Bicyclo[2.2.1]hept-2-yloxy]-4-methoxyp henyl…monomer335-681
ZN;0CP;MG;
Assess
Crystal structure of PDE4B2B complexed with Rolipram (R & S)monomer324-667
ZN;MN;ARS;ROL;
Assess
CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH AMPmonomer324-661
ZN;AMP;
Assess
CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH 8-Br-AMPmonomer324-661
ZN;8BR;
Assess
Crystal structure of human phosphodiesterase 4B catalytic domain with inhibitor NPD-001monomer323-659
ZN;MG;ACT;6M5;
Assess
Human phosphodiesterase 4B catalytic domain in complex with a pyrrolidinyl inhibitor.monomer323-658
ZN;MG;9VE;
Assess
Catalytic domain of human phosphodiesterase 4B2B in complex with a quinoline inhibitormonomer324-659
066;ZN;MG;ARS;GOL;
Assess
Crystal structure of PDE4B catalytic domain in complex with a pyrazolopyridine inhibitormonomer324-659
ZN;MG;20A;ARS;
Assess
PDE4B bound to MAPI compound 92amonomer323-658
ZN;MG;VL9;
Assess
Catalytic domain of human phosphodiesterase 4b2b in complex with a 5-heterocycle pyrazolopyridine i…monomer324-659
ZN;MG;ARS;ZG2;GOL;
Assess
Catalytic domain of human phosphodiesterase 4b2b in complex with a 5-heterocycle pyrazolopyridine i…monomer325-659
ZN;MG;ARS;ZG1;GOL;
Assess
Crystal structure of PDE4B2B in complex with inhibitor NPVmonomer324-657
ZN;MG;NPV;
Assess
Catalytic Domain of Human Phosphodiesterase 4B in Complex with A Coumarin-Based Inhibitormonomer324-657
Z72;ZN;MG;SO4;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Roflumilastmonomer327-657
ZN;MG;ROF;
Assess
Crystal structure of human phosphodiesterase 4B (PDE4B) in complex with a [1,3,5]triazine derivativemonomer334-657
1S1;MG;ZN; 19×EDO;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Sildenafilmonomer334-657
ZN;MG;SO4;VIA;
Assess
Human Phospodiesterase 4B in complex with pyridyloxy-benzoxaborole based inhibitormonomer334-656
ZN;MG;6QQ; 17×EDO;
Assess
PDE4B In complex with ligand an2898monomer334-656
ZN;MG;3OJ; 14×EDO;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Filaminastmonomer335-657
ZN;MG;FIL;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With AMPmonomer335-657
ZN;MG;AMP;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Cilomilastmonomer335-657
ZN;MG;CIO;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R,S)-Roliprammonomer335-657
ZN;MG;ROL;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Piclamilastmonomer335-657
ZN;MG;PIL;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Vardenafilmonomer335-657
ZN;MG;VDN;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With 1-(2-chloro-phenyl)-3,5-dimethyl-1H-…monomer335-657
ZN;MG;6DE;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Roliprammonomer335-657
ZN;MG;ROL;
Assess
Catalytic Domain Of Human Phosphodiesterase 4B In Complex With 3,5-dimethyl-1-(3-nitro-phenyl)-1H-p…monomer335-657
ZN;MG;7DE;
Assess
Crystal structure of N2 substituted pyrazolo pyrimidinones - a flipped binding mode in PDE5monomer451-476
ZN;MG;3P4;MES;
Assess
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN5004monomer663-673
ZN;MG;E31;CL;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3g45.1.Ahomo-2-mer0.80247-658
ZN;988;98.07
Assess
4wzi.1.Ahomo-2-mer0.76166-657
ZN;97.89
Assess

6 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23g45.1.Ahomo-2-mer0.8075-486
ZN;988;98.07
Assess
Isoform 24wzi.1.Ahomo-2-mer0.7740-485
ZN;97.71
Assess
Isoform 33g45.1.Ahomo-2-mer0.80232-643
ZN;988;98.07
Assess
Isoform 34wzi.1.Ahomo-2-mer0.76151-642
ZN;97.89
Assess
Isoform 43g45.1.Ahomo-2-mer0.8114-425
ZN;988;96.14
Assess
Isoform 44wzi.1.Ahomo-2-mer0.8016-424
ZN;97.75
Assess